|Bid||0.3378 x 1400|
|Ask||0.3400 x 1000|
|Day's Range||0.3330 - 0.3599|
|52 Week Range||0.2300 - 3.3200|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CLVS
Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term.
Clovis (CLVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I’m just going to stick with the hard numbers. Whether you agree or not is more of a tertiary issue. Primarily, it’s vital that you at least recognize the obstacles with these investments. To be clear, this list of stocks to sell will not impugn the core narrative of the underlying companies. Frankly, virtually every cap